Glyciphage-VG1 Tablet SR
Glyciphage-VG1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹69
that's 68% off!
About This Medicine
Product description & overview
Glyciphage-VG1 Tablets: A Multi-Action Approach to Blood Sugar Control
Glyciphage-VG1 combines three powerful medications in one tablet form for effective blood sugar management:
Glimepiride (1mg) - This sulfonylurea medication helps your pancreas release more insulin, allowing your body to utilize glucose effectively.
Metformin (500mg) - A first-line treatment for type 2 diabetes, metformin helps lower blood glucose levels by decreasing the amount of sugar produced by your liver and improving insulin sensitivity.
Voglibose (0.2mg) - This α-glucosidase inhibitor prevents digestion of carbohydrates in the gut, further aiding in preventing postprandial hyperglycemia.
Glyciphage-VG1 is designed for patients with type 2 diabetes who require a comprehensive approach to blood sugar management. It is formulated as Sustained Release tablets, ensuring consistent and prolonged drug release over time. This medication should only be used under the guidance of a qualified healthcare professional.
Please Note: This product description is intended for informational purposes only and does not substitute for professional medical advice.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glyciphage-VG1 Tablet SR.
High Risk
Pregnancy
Glyciphage-VG1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glyciphage-VG1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glyciphage-VG1 Tablet SR may be needed. Please consult your doctor. Glyciphage-VG1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glyciphage-VG1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glyciphage-VG1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glyciphage-VG1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glyciphage-VG1 Tablet SR
Products matching your search
Glypten-M Forte 1000mg/20mg Tablet
Glypten-M Forte 1000mg/20mg Tablet
Goodzox Tablet
Goodzox Tablet
Essita 10 Tablet
Essita 10 Tablet
Y-Cort 6 Tablet
Y-Cort 6 Tablet
Citrawel B6 Oral Solution Raspberry Sugar Free
Citrawel B6 Oral Solution Raspberry Sugar Free
Hald 200 Soft Gelatin Capsule
Hald 200 Soft Gelatin Capsule
Enuff Extra Sachet
Enuff Extra Sachet
Esocaid-DSR Capsule